Matches in Nanopublications for { ?s ?p "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP242739.RAfEV4OEuEKlcxLzIe1y9KaRaiDU6vSZRDjKbSlpWwNdE130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242739.RAfEV4OEuEKlcxLzIe1y9KaRaiDU6vSZRDjKbSlpWwNdE130_provenance.
- NP368042.RAfO-EVneGjDhDcYcN4n9wKXQyH5XLgQ1jpXqW3J1TGBk130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368042.RAfO-EVneGjDhDcYcN4n9wKXQyH5XLgQ1jpXqW3J1TGBk130_provenance.
- NP806238.RAssYPtMN8c66tlg2WCwCG8gTWOuXsrd7odVyFaj3FN6w130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806238.RAssYPtMN8c66tlg2WCwCG8gTWOuXsrd7odVyFaj3FN6w130_provenance.
- NP720700.RATvi3sDQwJDA_v40KCEULf2a7Mum1QRQsARaZuyF-3io130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720700.RATvi3sDQwJDA_v40KCEULf2a7Mum1QRQsARaZuyF-3io130_provenance.
- NP818835.RA9gE9MwtBHTOqe8F95vqqPLJwpgZxayuKVEHOmaG3qfI130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818835.RA9gE9MwtBHTOqe8F95vqqPLJwpgZxayuKVEHOmaG3qfI130_provenance.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP771804.RArvPBHUBRNj11ftSpUWzNOwg7zeGMtRhT4Z7bCzqR1BE130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771804.RArvPBHUBRNj11ftSpUWzNOwg7zeGMtRhT4Z7bCzqR1BE130_provenance.
- NP232455.RAgTPOC4Y5LWAYC7AetWozWXDa9HYl1X_VgGQHjoyRYRc130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232455.RAgTPOC4Y5LWAYC7AetWozWXDa9HYl1X_VgGQHjoyRYRc130_provenance.
- NP678326.RALhWwc3YWVrTcjyWWUg8a-l-VYgIie3-I-B9LOLkZwSI130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678326.RALhWwc3YWVrTcjyWWUg8a-l-VYgIie3-I-B9LOLkZwSI130_provenance.
- NP678325.RAwOZCL5Io8vaci0KqYQKlDm8bCB-CrusltSGEYIIkvOM130_assertion description "[Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP678325.RAwOZCL5Io8vaci0KqYQKlDm8bCB-CrusltSGEYIIkvOM130_provenance.